ATC/DDD

ATC/DDD index C10BA

You are here: Home > ATC/DDD > C > C10 > C10B

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- C
CARDIOVASCULAR SYSTEM
- C10
LIPID MODIFYING AGENTS
- C10B
LIPID MODIFYING AGENTS, COMBINATIONS

C10BA

HMG CoA reductase inhibitors in combination with other lipid modifying agents

ATC/DDD code C10BA for HMG CoA reductase inhibitors in combination with other lipid modifying agents

The DDD for the fixed combination of simvastatin or atorvastatin and ezetimibe is 1 UD (1 tablet), regardless of strength.

The DDD for the fixed combination of pravastatin and fenofibrate is 1 UD (1 tablet), regardless of strength.

C10BA01
lovastatin and nicotinic acid
C10BA02
simvastatin and ezetimibe
C10BA03
pravastatin and fenofibrate
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us